Stock listing
Os Therapies Incorporated
Selected listing: OSTX · AMEX · USD · US
Os Therapies Incorporated (NYSE American: OSTX), Health Technology. Latest release Oct 1, 2026: OS Therapies Appoints Kerry Clem as Chief Commercial Officer…
- Ticker
- NYSE American: OSTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
About Os Therapies Incorporated
The company focuses on developing innovative therapies and solutions in its field. Investors can find relevant information about its operations and performance on its public company page.
Latest news from Os Therapies Incorporated
OS Therapies Appoints Kerry Clem as Chief Commercial Officer and Frank Knuettel II as Chief Financial Officer
October 1, 2026
OS Therapies Announces Brand Name 'Herlystic' Approved by World Health Organization for OST-HER2 (daznelimgene lisbac)
September 24, 2026
OS Therapies Completes FDA Type C Statistical Methods Meeting and Provides Update on Global Regulatory Coordination for OST-HER2 Under Project Orbis
September 21, 2026
OS Therapies Achieves Incremental Alignment With FDA and Accepts Project Orbis Invitation From MHRA on OST-HER2 Metastatic Osteosarcoma Program
September 17, 2026
OS Therapies Announces Full Alignment with UK MHRA and EU EMA for Conditional Marketing Authorisation Application Filing
September 15, 2026
Research Os Therapies Incorporated
Os Therapies Incorporated company profile
View the public company page for Os Therapies Incorporated on 6ix.
Os Therapies Incorporated news
Read company news and market updates connected to Os Therapies Incorporated.
Os Therapies Incorporated investor events
Find investor webinars, events, and replay context for Os Therapies Incorporated.